17 Aug Cefepime hydrochloride – Risk of serious adverse reactions
Posted at 13:09h in
Risk of serious adverse reactions, including encephalopathy, associated with MAXIPIME (cefepime hydrochloride) particularly in patients with renal impairment who received doses that exceeded the dosage recommendations.
Download latest version
Document Number: DHCPL
Date Updated: 17/04/2019
File Type: pdf
Category: Communication To Health Care Professionals